Literature DB >> 9271828

Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene.

K Kotsch1, J Wehling, S Köhler, R Blasczyk.   

Abstract

We present a sequencing-based typing strategy for the HLA-A locus that is generally applicable to all HLA class I genes. Sequencing-based typing is the method of choice for matching in unrelated bone marrow transplantation on the allelic level. We determined the noncoding sequences of all serological antigens and most of their subtypes and discovered a remarkably conserved diversity characterized by polymorphic sequence motifs. In this study we took advantage of this diversity we uncovered in the 5' flanking region, 5' untranslated region and in the introns 1, 2 and 3, which was related to serological families. We established 12 primer mixes for setting up a PCR-based template preparation. Our strategy is based on the separate amplification of haplotypes and therefore defines the cis/trans linkage of polymorphic sequence motifs. This allowed individual sequencing of the haplotypes in all samples heterozygous for the broad antigens as well as the complete analysis of the polymorphic exons 2 and 3. All templates included the 2nd intron which was used as a priming site for the gene-specific 5' and 3' universal sequencing primers regardless of the amplified haplotypes. The independent sequencing of the haplotypes allows the application of the dye terminator cycle sequencing technique, which is less time-consuming and less-laborious than dye primer chemistry. The lack of heterozygous positions essentially facilitates on the one hand the data analysis and on the other hand the detection of new alleles. Sequencing is only required in one direction due to the absence of peak shift problems. The results will remain unambiguous regardless of a growing HLA sequence data bank since this sequencing technique defines the cis/trans linkage of sequence motifs in more than 95% of the cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271828     DOI: 10.1111/j.1399-0039.1997.tb02857.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Aberrant expression of HLA-B*3565Q is associated with a disrupted disulfide bond.

Authors:  Holger-Andreas Elsner; Peter A Horn; Constanze Schoenemann; Wolfgang W Altermann; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2006-10-06       Impact factor: 2.846

2.  Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing.

Authors:  Shengli Song; Miaomiao Han; Han Zhang; Yuanxia Wang; Hong Jiang
Journal:  Cell Mol Immunol       Date:  2013-08-19       Impact factor: 11.530

3.  A one-step DNA sequencing strategy to HLA type hematopoietic stem cell donors at recruitment - rethinking typing strategies.

Authors:  B Tu; N Cha; R Yang; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2013-03

4.  Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.

Authors:  Lisa E Creary; Sandra G Guerra; Winnie Chong; Colin J Brown; Thomas R Turner; James Robinson; Will P Bultitude; Neema P Mayor; Steven G E Marsh; Katsuyuki Saito; Kevin Lam; Jamie L Duke; Timothy L Mosbruger; Deborah Ferriola; Dimitrios Monos; Amanda Willis; Medhat Askar; Gottfried Fischer; Chee Loong Saw; Jiannis Ragoussis; Martin Petrek; Carles Serra-Pagés; Manel Juan; Catherine Stavropoulos-Giokas; Amalia Dinou; Reem Ameen; Salem Al Shemmari; Eric Spierings; Ketevan Gendzekhadze; Gerald P Morris; Qiuheng Zhang; Zahra Kashi; Susan Hsu; Sridevi Gangavarapu; Kalyan C Mallempati; Fumiko Yamamoto; Kazutoyo Osoegawa; Tamara Vayntrub; Chia-Jung Chang; John A Hansen; Marcelo A Fernández-Viňa
Journal:  Hum Immunol       Date:  2019-03-04       Impact factor: 2.850

5.  Next-generation sequencing reveals new information about HLA allele and haplotype diversity in a large European American population.

Authors:  Lisa E Creary; Sridevi Gangavarapu; Kalyan C Mallempati; Gonzalo Montero-Martín; Stacy J Caillier; Adam Santaniello; Jill A Hollenbach; Jorge R Oksenberg; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2019-07-22       Impact factor: 2.850

6.  Description of the first HLA-DRB1 null allele.

Authors:  Britta Eiz-Vesper; Rainer Blasczyk; Peter A Horn
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

7.  High-resolution HLA allele and haplotype frequencies in several unrelated populations determined by next generation sequencing: 17th International HLA and Immunogenetics Workshop joint report.

Authors:  Lisa E Creary; Nicoletta Sacchi; Michela Mazzocco; Gerald P Morris; Gonzalo Montero-Martin; Winnie Chong; Colin J Brown; Amalia Dinou; Catherine Stavropoulos-Giokas; Clara Gorodezky; Saranya Narayan; Srinivasan Periathiruvadi; Rasmi Thomas; Dianne De Santis; Jennifer Pepperall; Gehad E ElGhazali; Zain Al Yafei; Medhat Askar; Shweta Tyagi; Uma Kanga; Susana R Marino; Dolores Planelles; Chia-Jung Chang; Marcelo A Fernández-Viña
Journal:  Hum Immunol       Date:  2021-05-24       Impact factor: 2.211

8.  HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

Authors:  U Amstutz; C J D Ross; L I Castro-Pastrana; M J Rieder; N H Shear; M R Hayden; B C Carleton
Journal:  Clin Pharmacol Ther       Date:  2013-03-18       Impact factor: 6.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.